Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,740,239,592
-
Number of holders
-
1,591
-
Total 13F shares, excl. options
-
1,273,140,330
-
Shares change
-
+10,884,949
-
Total reported value, excl. options
-
$67,943,393,768
-
Value change
-
+$614,368,368
-
Put/Call ratio
-
74%
-
Number of buys
-
617
-
Number of sells
-
-769
-
Price
-
$53.36
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q3 2017
1,707 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q3 2017.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,591 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,273,140,330 shares
of 1,740,239,592 outstanding shares and own 73% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (131,801,606 shares), BlackRock Inc. (106,634,653 shares), STATE STREET CORP (73,122,284 shares), Capital Research Global Investors (67,861,126 shares), WELLINGTON MANAGEMENT GROUP LLP (51,166,477 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (49,172,292 shares), Bank of New York Mellon Corp (32,561,649 shares), PRICE T ROWE ASSOCIATES INC /MD/ (27,638,230 shares), NORTHERN TRUST CORP (27,281,684 shares), and BANK OF AMERICA CORP /DE/ (22,928,451 shares).
This table shows the top 1,591 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.